Argenx

VYVGART

Manufacturer:

Argenx

Vyvgart HCPCS:

J9332

HCPCS Code Descriptor:

Injection, efgartigimod alfa-fcab, 2mg

Category:

J Code

Vyvgart NDCs:

73475-3041-05

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Vyvgart CPT Codes:

Potential CPT administration codes for Vyvgart can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Vyvgart:

VYVGART is an Oncology drug manufactured by Argenx and administered via the Intravenous route of administration. The J Code: J9332 is aligned to the drug VYVGART.

ACCESS PRICING AND MORE BY REGISTERING

J9332 Added Date:

July 1, 2022

J9332 Effective Date:

July 1, 2022

J9332 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Vyvgart billing and coding information.
Vyvgart patient assistance information can be found through My VYVGART Path at the URL: https://vyvgart.com/
VYVGART prescribing information can be found at the link below:
Information regarding VYVGART’s side effects can be found at MedlinePlus